Legal & General Group Plc - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 3 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$2,283,142
-59.2%
243,665
+6.9%
0.00%
-50.0%
Q2 2023$5,592,422
+8.2%
227,983
+2.6%
0.00%0.0%
Q1 2023$5,170,641
-8.1%
222,202
-0.1%
0.00%0.0%
Q4 2022$5,627,400
+33.6%
222,339
+1.8%
0.00%0.0%
Q3 2022$4,212,000
-22.8%
218,438
+2.0%
0.00%0.0%
Q2 2022$5,457,000
+283.8%
214,257
+287.6%
0.00%
Q1 2022$1,422,000
-38.2%
55,275
+0.6%
0.00%
-100.0%
Q4 2021$2,301,000
-2.0%
54,960
+1.9%
0.00%0.0%
Q3 2021$2,347,000
+11.1%
53,934
+20.7%
0.00%0.0%
Q2 2021$2,113,000
+45.7%
44,680
+57.8%
0.00%0.0%
Q1 2021$1,450,000
+49.9%
28,309
-21.7%
0.00%
Q4 2020$967,000
+3.2%
36,160
+32.5%
0.00%
Q3 2020$937,000
-19.5%
27,285
-4.1%
0.00%
-100.0%
Q2 2020$1,164,000
+2884.6%
28,445
+2419.5%
0.00%
Q1 2020$39,000
+105.3%
1,129
-23.8%
0.00%
Q4 2019$19,0001,4820.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q4 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$38,245,75330.44%
SB INVESTMENT ADVISERS (UK) LTD 16,684,041$409,259,5263.12%
Octagon Capital Advisors LP 650,100$15,946,9532.22%
Paradigm Biocapital Advisors LP 1,014,239$24,879,2831.92%
Perceptive Advisors 1,958,264$48,036,2161.39%
Avidity Partners Management LP 1,425,000$34,955,2501.22%
Ghost Tree Capital, LLC 150,000$3,679,5001.22%
MIRABELLA FINANCIAL SERVICES LLP 412,008$10,106,5561.11%
SECTOR GAMMA AS 150,406$3,689,4590.83%
Sofinnova Investments, Inc. 488,117$11,973,5100.78%
View complete list of VIR BIOTECHNOLOGY INC shareholders